Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis

[1]  Perminder S Sachdev,et al.  Increase in PAS-induced neuroplasticity after a treatment course of transcranial direct current stimulation for depression. , 2014, Journal of affective disorders.

[2]  M. Vinberg,et al.  Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients , 2014, Psychoneuroendocrinology.

[3]  B. Penninx,et al.  Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484) , 2014, Molecular Psychiatry.

[4]  A. Brunoni,et al.  BDNF blood levels after electroconvulsive therapy in patients with mood disorders: A systematic review and meta-analysis , 2014, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[5]  M. Nitsche,et al.  BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial , 2014, European Neuropsychopharmacology.

[6]  Michael Breakspear,et al.  Modulation of Cortical Activity by Transcranial Direct Current Stimulation in Patients with Affective Disorder , 2014, PloS one.

[7]  M. Furey,et al.  DEVELOPING BIOMARKERS IN MOOD DISORDERS RESEARCH THROUGH THE USE OF RAPID‐ACTING ANTIDEPRESSANTS , 2014, Depression and anxiety.

[8]  I. Benseñor,et al.  Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial , 2014, Psychopharmacology.

[9]  F. Fregni,et al.  Biological Markers in Noninvasive Brain Stimulation Trials in Major Depressive Disorder: A Systematic Review , 2014, The journal of ECT.

[10]  F. Fregni,et al.  Enhancement of Affective Processing Induced by Bifrontal Transcranial Direct Current Stimulation in Patients With Major Depression , 2014, Neuromodulation : journal of the International Neuromodulation Society.

[11]  F. Fregni,et al.  Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study. , 2013, The international journal of neuropsychopharmacology.

[12]  Wei He,et al.  Effects of electroacupuncture on depression and the production of glial cell line-derived neurotrophic factor compared with fluoxetine: a randomized controlled pilot study. , 2013, Journal of alternative and complementary medicine.

[13]  O. Pogarell,et al.  Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression. , 2013, Journal of affective disorders.

[14]  R. Pandey,et al.  Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity. , 2013, Journal of affective disorders.

[15]  M. Amore,et al.  NGF serum levels variations in major depressed patients receiving duloxetine , 2013, Psychoneuroendocrinology.

[16]  F. Fregni,et al.  Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the Major Depressive Episode: Findings from a naturalistic study , 2013, European Psychiatry.

[17]  X. Tian,et al.  Low-frequency (1Hz) repetitive transcranial magnetic stimulation (rTMS) reverses Aβ1–42-mediated memory deficits in rats , 2013, Experimental Gerontology.

[18]  S. Borgwardt,et al.  Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies , 2013, Cellular Physiology and Biochemistry.

[19]  F. Fregni,et al.  The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. , 2013, JAMA psychiatry.

[20]  C. Plewnia,et al.  Amelioration of Cognitive Control in Depression by Transcranial Direct Current Stimulation , 2013, Biological Psychiatry.

[21]  Felipe Fregni,et al.  Acute working memory improvement after tDCS in antidepressant-free patients with major depressive disorder , 2013, Neuroscience Letters.

[22]  S. Salton,et al.  The role of neurotrophins in major depressive disorder , 2013, Translational neuroscience.

[23]  J. Rybakowski,et al.  Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved? , 2013, Human psychopharmacology.

[24]  Felipe Fregni,et al.  Transcranial direct current stimulation for the treatment of major depressive disorder: A summary of preclinical, clinical and translational findings , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  C. Nemeroff,et al.  Heartache and heartbreak—the link between depression and cardiovascular disease , 2012, Nature Reviews Cardiology.

[26]  L. Merabet,et al.  Clinical research with transcranial direct current stimulation (tDCS): Challenges and future directions , 2012, Brain Stimulation.

[27]  O. Forlenza,et al.  Reduced serum nerve growth factor in patients with late-life depression. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[28]  M. de Tommaso,et al.  Serum levels of N-acetyl-aspartate in migraine and tension-type headache , 2012, The Journal of Headache and Pain.

[29]  Ellen Frank,et al.  Major depressive disorder: new clinical, neurobiological, and treatment perspectives , 2012, The Lancet.

[30]  D. Veltman,et al.  Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: A systematic review , 2012, Neuroscience & Biobehavioral Reviews.

[31]  Donel M. Martin,et al.  Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial , 2012, British Journal of Psychiatry.

[32]  J. Micó,et al.  Neurotrophins Role in Depression Neurobiology: A Review of Basic and Clinical Evidence , 2011, Current neuropharmacology.

[33]  Takayoshi Suzuki,et al.  Epigenetic Status of Gdnf in the Ventral Striatum Determines Susceptibility and Adaptation to Daily Stressful Events , 2011, Neuron.

[34]  Courtney A. Miller.  Stressed and Depressed? Check Your GDNF for Epigenetic Repression , 2011, Neuron.

[35]  Zhijun Zhang,et al.  Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients. , 2010, Journal of affective disorders.

[36]  M. Riva,et al.  Serum and plasma BDNF levels in major depression: A replication study and meta-analyses , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[37]  Heidi M. Schambra,et al.  Direct Current Stimulation Promotes BDNF-Dependent Synaptic Plasticity: Potential Implications for Motor Learning , 2010, Neuron.

[38]  A. Priori,et al.  Comparative benefits of transcranial direct current stimulation (TDCS) treatment in patients with mild/moderate vs. severe depression , 2009 .

[39]  M. Nitsche,et al.  Serotonin Affects Transcranial Direct Current–Induced Neuroplasticity in Humans , 2009, Biological Psychiatry.

[40]  J. Geddes,et al.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.

[41]  R. Wynn,et al.  Neurotrophic factors in serum following ECT: A pilot study , 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[42]  Felipe Fregni,et al.  A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. , 2008, The international journal of neuropsychopharmacology.

[43]  M. Fava,et al.  Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder , 2008, Dialogues in clinical neuroscience.

[44]  Yoshifumi Watanabe,et al.  Altered expression of neurotrophic factors in patients with major depression. , 2008, Journal of psychiatric research.

[45]  R. Duman,et al.  Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.

[46]  L. Cohen,et al.  Transcranial direct current stimulation: State of the art 2008 , 2008, Brain Stimulation.

[47]  I. Heuser,et al.  Serum Concentrations of Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Depressed Patients before and after Antidepressant Treatment , 2008, Pharmacopsychiatry.

[48]  Sergio P. Rigonatti,et al.  Go-no-go task performance improvement after anodal transcranial DC stimulation of the left dorsolateral prefrontal cortex in major depression. , 2007, Journal of affective disorders.

[49]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[50]  L. Cohen,et al.  Transcranial DC stimulation (tDCS): A tool for double-blind sham-controlled clinical studies in brain stimulation , 2006, Clinical Neurophysiology.

[51]  Helena C Kraemer,et al.  Centring in regression analyses: a strategy to prevent errors in statistical inference , 2004, International journal of methods in psychiatric research.

[52]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[53]  P. Jerabek,et al.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response , 2000, Biological Psychiatry.

[54]  M. Nitsche,et al.  Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation , 2000, The Journal of physiology.

[55]  P. Amorim.  Mini International Neuropsychiatric Interview (MINI): validacao de entrevista breve para diagnostico de transtornos mentais , 2000 .

[56]  G. L. Curran,et al.  Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. , 1996, Brain research. Molecular brain research.

[57]  O. Forlenza,et al.  Circulating Glial-derived neurotrophic factor is reduced in late-life depression. , 2012, Journal of psychiatric research.

[58]  F. Fregni,et al.  Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives. , 2011, Contemporary clinical trials.

[59]  C. Martini,et al.  Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. , 2008, Journal of affective disorders.

[60]  Antônio Waldo Zuardi,et al.  Escalas de avaliação clínica em psiquiatria e psicofarmacologia , 2000 .